Skip Nav Destination
Close Modal
Roberto Abadie
Roberto Abadie
Roberto Abadie
Roberto Abadie
Roberto Abadie
Roberto Abadie
Sharon R. Kaufman
1-20 of 24 Search Results for
pharma
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Published: 09 July 2010
DOI: 10.1215/9780822393245-005
EISBN: 978-0-8223-9324-5
Published: 09 July 2010
DOI: 10.1215/9780822393245
EISBN: 978-0-8223-9324-5
Series: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
EISBN: 978-0-8223-7550-0
... biomedical research randomized controlled trial therapeutics Big Pharma ...
Series: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
EISBN: 978-0-8223-7550-0
... Medicare treatment standards Big Pharma medical cost reimbursement ...
Published: 07 October 2016
EISBN: 978-0-8223-7364-3
... uncertain productivity of bioethics indigenous donors bioethics informed consent biomedical platform big pharma ...
Series: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
EISBN: 978-0-8223-7550-0
...” medicine. Through them, research findings from experimental studies are converted into best evidence for treatment. That conversion is the first of the four transformations that constitute contemporary medicine. biomedical research randomized controlled trial therapeutics Big Pharma...
Published: 09 July 2010
EISBN: 978-0-8223-9324-5
Published: 09 July 2010
EISBN: 978-0-8223-9324-5
Published: 09 July 2010
DOI: 10.1215/9780822393245-011
EISBN: 978-0-8223-9324-5
Published: 09 July 2010
DOI: 10.1215/9780822393245-012
EISBN: 978-0-8223-9324-5
Published: 09 July 2010
DOI: 10.1215/9780822393245-008
EISBN: 978-0-8223-9324-5
Book Chapter
Published: 09 July 2010
DOI: 10.1215/9780822393245-006
EISBN: 978-0-8223-9324-5
Book Chapter
Published: 09 July 2010
DOI: 10.1215/9780822393245-003
EISBN: 978-0-8223-9324-5
Published: 09 July 2010
DOI: 10.1215/9780822393245-004
EISBN: 978-0-8223-9324-5
Book Chapter
Published: 09 July 2010
DOI: 10.1215/9780822393245-007
EISBN: 978-0-8223-9324-5
Published: 09 July 2010
DOI: 10.1215/9780822393245-009
EISBN: 978-0-8223-9324-5
Book Chapter
Published: 09 July 2010
DOI: 10.1215/9780822393245-002
EISBN: 978-0-8223-9324-5
Book Chapter
Published: 09 July 2010
DOI: 10.1215/9780822393245-001
EISBN: 978-0-8223-9324-5
Book Chapter
Published: 09 July 2010
DOI: 10.1215/9780822393245-010
EISBN: 978-0-8223-9324-5
Book Chapter
Series: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
DOI: 10.1215/9780822375500-004
EISBN: 978-0-8223-7550-0
...: the fact that the pharmaceutical and biotech industries and the for-profit market for technologies have a growing impact on shaping research agendas and thus on shaping treatments. Medicare treatment standards Big Pharma medical cost reimbursement ...
1
